A. Łęczycka, “PHARMACOTHERAPY IN MUSCLE DYSMORPHIC DISORDER: CLINICAL CONSIDERATIONS AND THE LIMITS OF EXTRAPOLATING EVIDENCE FROM BODY DYSMORPHIC DISORDER”, IJITSS, vol. 3, no. 2(50), Jun. 2026, doi: 10.31435/ijitss.2(50).2026.5359.